Nearly 20% of patients with type 2 diabetes do not benefit from exercise
the ONA take:
According to a new study published in the Journal of Clinical Endocrinology & Metabolism, one in five people with type 2 diabetes mellitus do not achieve any improvement in blood sugar control when they participate in a supervised exercise regimen.
For the study, researchers analyzed data from clinical studies that investigated the use of exercise regimens in patients with type 2 diabetes. They also looked at animal and genetic studies that did the same. Results showed that about 15 to 20% of patients with type 2 diabetes did not experience improvement in blood sugar control, insulin sensitivity, or muscle mitochondrial density.
The animal and genetic studies suggest that the resistance to exercise is genetic and can be passed from one generation to the next.
The U.S. Centers for Disease Control and Prevention estimates that about 40% of American will develop type 2 diabetes in their lifetime. Because obesity and lack of exercise are associated with the disease, exercise is often recommended to patients with diabetes to help manage the disease.
This study shows that while most people benefit from exercise, nearly 20% of patients with type 2 diabetes do not as a result of their DNA.
One in five people with type 2 diabetes mellitus do not achieve any improvement in blood sugar control.
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- Breast Conservation Improves Survival vs Mastectomy in Breast Cancer
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
- Affect of Daratumumab on Laboratory Blood Test Results
- Geriatric Consults Rare in Kidney Cancer Care
- Worse Survival Seen for Alternative Versus Usual Cancer Therapy
- Anorexia-Cachexia in Non-Small Cell Lung Cancer Improved With Anamorelin
- Early Recognition of Checkpoint Inhibitor-Related Pneumonitis Improves Outcomes
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|